Home

DiaMedBase 

Diabetes Medicinal Plant Database

Browse    A B C D E F G H I J K L M N O P Q R S T U V W X Y Z     Plants List
Caesalpinia
Cajanus
Calamintha
Camellia
Capparis
Capsicum
Caralluma
Carissa
Carum
Casearia
Cassia
Castanospermum
Catharanthus
Cecropia
Centaurea
Centaurium
Cephalandra
Chamaemelum
Chelidonium
Chrysanthemum
Chrysobalanus
Cicer
Cichorium
Cimicifuga
Cinnamomum
Cirsium
Cissus
Citrullus
Citrus
Clausena
Cleome
Cnidium
Cnidoscolus
Coccinia
Cogniauxia
Colocassia
Commelina
Commiphora
Convallaria
Convolvulus
Coptis
Coriandrum
Corni
Cornus
Coscinium
Costus
Cressa
Crotalaria
Croton
Cryptolepis
Cucumis
Cucurbita
Cuminum
Curcuma
Cyamopsis
Cyclocarya
Cymbopogon
 
DiaMedBase ID   DMPCc193
Medicinal Plant   Commelina communis
Plant part(s)   Whole plant
Objective   To study the potent inhibitory activity against alpha-glucosidase
Journal Source   Planta Med. 1999; 65(5):437-439
Title   alpha-Glucosidase inhibitors from Commelina communis
Authors   Kim HS, Kim YH, Hong YS, Paek NS, Lee HS, Kim TH, Kim KW, Lee JJ
Address   Not available
Abstract   A methanolic extract of Commelina communis showed potent inhibitory activity against alpha-glucosidase. One pyrrolidine alkaloid, 2,5-dihydroxymethyl-3,4-dihydroxypyrrolidine (DMDP, 1) and four piperidine alkaloids, 1-deoxymannojirimycin (2), 1-deoxynojirimycin (3), alpha-homonojirimycin (4) and 7-O-beta-D-glucopyranosyl alpha-homonojirimycin (5) were isolated by bioassay-directed fractionation and separation. These compounds have been identified for the first time from Commelina communis, supporting the pharmacological basis of this plant that has been used as a traditional herbal medicine for the treatment of diabetes.
Diseases   Disease Link
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

          Copyright © 2006 ProGene Biosciences
            Last modified: March, 2006
             info@progenebio.in